EDGEWELL PERSONAL CARE Co EPC

Healthcare SIC 2844 - Perfumes, Cosmetics & Other Toilet Preparations NYSE

Edgewell Personal Care Company, and its subsidiaries, is one of the world's largest manufacturers and marketers of personal care products in the Wet Shave, Sun and Skin Care, and Feminine Care segments. With operations in approximately 20 countries, our products are widely available in more than 50 countries.

We were incorporated in the State of Missouri on September 23, 1999 and, prior to April 2000, were a wholly-owned subsidiary of Ralston Purina Company. On April 1, 2000, all of the outstanding shares of our common stock were distributed to shareholders of Ralston Purina Company and we became an independent publicly-owned company. During the years that followed, we implemented a strategy of acquiring several personal care brands, which created the foundation for the company we are today.

Last close 28.87 2026-09-04
Market cap $1.33B 2026-06-30 share count
52-week range 15.72 - 29.95

Valuation FY2025 figures against the last close

P/S0.6x
P/E54.5x
P/FCF32.1x
EV/EBITDA13.4x
Dividend yield2.2%
Diluted EPS0.53

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $2.22B$2.25B$2.25B$2.17B$2.09B$1.95B$2.14B$2.23B$2.30B$2.36B
Cost of revenue $1.30B$1.30B$1.31B$1.29B$1.14B$1.07B$1.17B$1.20B$1.17B$1.20B
Gross profit $924.9M$955.7M$940.8M$880.5M$951.2M$880.9M$966.6M$1.03B$1.13B$1.16B
R&D $57.6M$58.4M$58.5M$55.5M$57.8M$55.3M$53.5M$61.1M$67.6M$71.9M
SG&A $425.0M$430.1M$409.6M
Operating income $96.6M$199.3M$227.0M$182.3M$239.9M$176.0M$243.8M
Interest expense $73.2M$76.5M$78.5M$71.4M$67.9M$61.2M$62.6M$68.0M$69.2M$71.8M
Pre-tax income $23.6M$120.9M$147.7M$124.1M$147.1M$87.3M-$390.3M$163.8M-$52.9M$219.9M
Income tax $1.8M$22.3M$33.0M$24.6M$29.3M$19.7M$18.1M$60.5M$58.6M$41.2M
Net income $25.4M$98.6M$114.7M$99.5M$117.8M$67.6M-$372.2M$103.3M$5.7M$178.7M
EPS, basic 0.531.982.241.872.171.25-6.881.900.103.02
EPS, diluted 0.531.972.211.852.131.24-6.881.900.102.99
Shares, diluted (wtd. avg.) $47.6M$50.1M$51.8M$53.6M$55.2M$54.6M$54.1M$54.5M$57.5M$59.7M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $225.7M$209.1M$216.4M$188.7M$479.2M$364.7M$341.6M$266.4M$502.9M$738.9M
Receivables $137.8M$109.4M$106.2M$136.9M$150.7M$158.8M$205.6M$226.5M$224.1M$260.7M
Inventory $484.7M$477.3M$492.4M$449.3M$345.7M$314.1M$357.2M$329.5M$333.5M$309.2M
Total current assets $995.5M$936.0M$962.4M$942.2M$1.14B$983.6M$1.04B$951.2M$1.19B$1.45B
Property, plant and equipment $369.3M$349.1M$337.9M$345.5M$362.6M$370.9M$396.0M$424.1M$453.4M$486.1M
Goodwill $1.29B$1.34B$1.33B$1.32B$1.16B$1.16B$1.03B$1.45B$1.45B$1.42B
Other intangibles $921.3M$948.5M$973.8M$996.6M$906.4M$928.1M$912.9M$1.10B$1.07B$1.39B
Total assets $3.76B$3.73B$3.74B$3.71B$3.67B$3.54B$3.42B$3.95B$4.19B$4.77B
Accounts payable $219.7M$219.3M$194.4M$228.8M$209.5M$181.9M$222.8M$238.4M$223.6M$196.5M
Short-term debt $0$0$0$117.0M$184.9M$0$281.8M
Total current liabilities $565.5M$563.6M$523.4M$539.5M$536.8M$510.5M$659.6M$717.0M$524.4M$868.2M
Long-term debt $1.38B$1.27B$1.36B$1.39B$1.23B$1.24B$1.10B$1.10B$1.53B$1.54B
Total liabilities $2.20B$2.15B$2.20B$2.25B$2.09B$2.11B$2.12B$2.21B$2.45B$2.94B
Retained earnings $1.09B$1.09B$1.02B$939.1M$865.7M$782.4M$714.8M$1.08B$952.9M$946.0M
Total equity $1.55B$1.58B$1.54B$1.47B$1.59B$1.44B$1.30B$1.74B$1.74B$1.83B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $118.4M-$231.0M-$216.1M$102.0M$229.0M$232.6M$190.6M$259.4M$313.6M$186.8M
Depreciation and amortisation $88.8M$88.0M$91.4M$89.9M$87.1M$88.8M$93.8M$97.6M$94.4M$92.6M
Stock-based compensation $24.5M$26.5M$27.5M$23.8M$27.3M$19.2M$17.8M$17.0M$22.2M$25.6M
Capital expenditure $77.0M$56.5M$49.5M$56.4M$56.8M$47.7M$58.0M$62.0M$69.0M$69.5M
Investing cash flow -$72.9M-$62.4M-$50.5M-$355.4M-$48.7M-$196.4M-$45.5M-$118.8M-$84.6M-$69.5M
Financing cash flow -$30.0M-$179.4M-$146.5M-$17.6M-$65.4M-$18.7M-$63.8M-$379.6M-$478.0M-$93.4M
Dividends paid $29.3M$30.7M$31.5M$32.6M$25.6M$0$0$0$0
Buybacks $90.2M$58.5M$75.2M$125.3M$9.2M$0$0$124.4M$165.4M$196.6M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001628280-25-052765.

Others in SIC 2844

TickerCompanyMarket capP/ERevenue growth
CL COLGATE PALMOLIVE CO $70.77B 33.8x 1.4%
EL ESTEE LAUDER COMPANIES INC $37.63B 207.7x 5.0%
KVUE Kenvue Inc. $36.00B 24.7x -2.1%
ELF e.l.f. Beauty, Inc. $6.47B 249.2x 24.6%
IPAR INTERPARFUMS INC $3.74B 22.3x 2.5%
COTY COTY INC. $2.58B -1.5%
WALD Waldencast plc $156.3M -0.7%
SLSN SOLESENCE, INC. $60.0M 42.5x 18.6%